ANAPROX Trademark

Trademark Overview

On Thursday, May 30, 2024, a trademark application was filed for ANAPROX with the United States Patent and Trademark Office. The USPTO has given the ANAPROX trademark a serial number of 98576017. The federal status of this trademark filing is WITHDRAWN BEFORE PUBLICATION as of Friday, December 19, 2025. This trademark is owned by Atnahs Pharma UK Limited. The ANAPROX trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics; Analgesic preparations; anti-inflammatory preparations.
anaprox

General Information

Serial Number98576017
Word MarkANAPROX
Filing DateThursday, May 30, 2024
Status692 - WITHDRAWN BEFORE PUBLICATION
Status DateFriday, December 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 6, 2026

Trademark Statements

Goods and ServicesAnalgesics; Analgesic preparations; anti-inflammatory preparations.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAtnahs Pharma UK Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEssex SS143FR
GB
Party NameAtnahs Pharma UK Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEssex SS143FR
GB

Trademark Events

Event DateEvent Description
Thursday, May 30, 2024NEW APPLICATION ENTERED
Wednesday, August 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 12, 2024ASSIGNED TO EXAMINER
Thursday, December 12, 2024NON-FINAL ACTION WRITTEN
Thursday, December 12, 2024NON-FINAL ACTION E-MAILED
Thursday, December 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, March 11, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, June 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 16, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 16, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 22, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 22, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 16, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 24, 2025TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, December 2, 2025ASSIGNED TO PETITION STAFF
Tuesday, December 2, 2025PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, December 2, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, December 16, 2025NOTICE OF ALLOWANCE CANCELLED
Friday, December 19, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Related Keywords

anaprox preparations inflammatory anti analgesics analgesic